Kidney cancer drug could slash the risk of repeated heart attacks in a similar way to statins, study suggests
A common drug used to treat kidney cancer could slash the risk of heart attacks, a study suggests. Cambridge University scientists found the anti-inflammatory medication, aldesleukin, reduced inflammation on a similar level to statins, cutting chances of a repeat attack. The results were so 'striking' that experts say the drug could change clinical practice, becoming a routine part of care for heart attack patients within five to ten years.
Read More >> Full Article on Source: ALPHA MAG
#US #ShowBiz #Sports #Politics #Celebs #Aurora Colorado #Anita #Digital_Sex_Crimes_in_Schools #Ricky Pearsall #Army #oasis2025
Post a Comment